These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Initial experiences of switching to faricimab for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in an Asian population. Ibrahim FNI; Teo KYC; Tan TE; Chan HH; Chandrasekaran PR; Lee SY; Tan ACS; Mathur R; Chan CM; Sim SS; Tan GSW; Yeo IYS; Cheung CMG Front Ophthalmol (Lausanne); 2023; 3():1346322. PubMed ID: 38982998 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study. Grimaldi G; Cancian G; Rizzato A; Casanova A; Perruchoud-Ader K; Clerici M; Consigli A; Menghini M Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1151-1159. PubMed ID: 38047930 [TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Pandit SA; Momenaei B; Wakabayashi T; Mansour HA; Vemula S; Durrani AF; Pashaee B; Kazan AS; Ho AC; Klufas M; Regillo C; Yonekawa Y; Hsu J; Kuriyan A; Chiang A Ophthalmol Retina; 2024 Apr; 8(4):360-366. PubMed ID: 37913992 [TBL] [Abstract][Full Text] [Related]
8. Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema. Quah NQX; Javed KMAA; Arbi L; Hanumunthadu D Clin Ophthalmol; 2024; 18():1479-1490. PubMed ID: 38827773 [TBL] [Abstract][Full Text] [Related]
9. Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration. Coney JM; Zubricky R; Sinha SB; Sonbolian N; Zhou L; Hull TP; Lewis SA; Miller DG; Novak MA; Pendergast SD; Pham H; Platt SM; Rao LJ; Schartman JP; Singerman LJ; Donkor R; Fink M; McCoy J; Karcher H Int J Retina Vitreous; 2023 Feb; 9(1):8. PubMed ID: 36726178 [TBL] [Abstract][Full Text] [Related]